Par Drugs and Chemicals-HY1-FY21 revenue was at Rs.28.32 crore against Rs. 29.11 crore in HY1-FY20.

Company : Par Drugs and Chemicals Limited

Par Drugs and Chemicals announced its standalone and consolidated financials for the half year ended on 30thseptember, 2020 marking a rise in post-tax gains as compared to a year ago period

.

Following are the standalone financial figures for the HY1-FY2021:

- Net profit stood at Rs.5.11 crore against Rs.1.58 crore in a year ago period.

- Revenue reached Rs.28.32 crore whereas last year corresponding period it was Rs.29.11 crore.

- Earning per share reached at Rs. 8.31 against EPS of Rs. 2.58 in the previous year, same period.

For the year that ended on 31st March, 2020, the company earned standalone total revenue of Rs.55.94 crore against Rs.46.41 crore a year ago. Net annual profit reached Rs.4.76 crore against Rs.2.51 crore last year. Earning per share was Rs. 7.75 whereas previous year it was Rs.5.60.

Recent Stories